Cole Pinnow - Jan 23, 2025 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Commercial Officer
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Stock symbol
COGT
Transactions as of
Jan 23, 2025
Transactions value $
$0
Form type
4
Date filed
1/27/2025, 05:00 PM
Previous filing
Jan 15, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +240K $0.00 240K Jan 23, 2025 Common Stock 240K $8.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.